IHS Chemical Week

Regions :: Western Europe :: Sweden

MPA inspection completed at Cambrex API facility in Sweden

1:13 AM MDT | March 27, 2014 | Deepti Ramesh

Cambrex (East Rutherford, NJ) says that the Medical Products Agency (MPA; Uppsala, Sweden) completed an inspection of Cambrex’s active pharmaceutical ingredient (API) manufacturing facility at Karlskoga, Sweden. The inspection found the site to be compliant with the principles and guidelines of GMP, and the site’s GMP certificate was renewed. The MPA authorities inspected the facility in September 2013. MPA is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing, and sale of drugs and other...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa